Interestingly, EGFP expression of MV-EdH in tissues and lymphocytes was significantly weaker than that of the wild-type MV. Taken together, these results indicate that the CD46-binding activity of the vaccine H protein is important for determining the cell specificity of MV in vitro but not the tropism in vivo. They also suggest that the vaccine H protein attenuates MV growth in vivo.
M easles remains a major cause of childhood morbidity and mortality worldwide especially in developing countries in spite of significant progress in global measles control programs. Measles virus (MV), belonging to the genus Morbillivirus of the family Paramyxoviridae, is an enveloped virus with a nonsegmented negative-strand RNA genome (11) . The MV genome encodes 6 structural proteins: the nucleocapsid (N), phospho (P), matrix (M), fusion (F), hemagglutinin (H), and large (L) proteins. Two envelope glycoproteins, the F and H proteins, initiate infection of the target cells via binding of the H protein to its cellular receptors. Therefore, the H protein is of primary importance for determining the cell specificity of MV (22) .
The Edmonston strain of MV was isolated in 1954 by using a primary culture of human kidney cells (7) . The Edmonston strain was subsequently adapted in a variety of cells, including chicken embryo fibroblasts, to enable the production of attenuated live vaccines, which are currently used worldwide (27) . These live, attenuated MV strains are safe and induce strong cellular and humoral immune responses against MV. The Edmonston vaccine strain is no longer pathogenic in monkey models (2, 7, 37, 39) . In contrast, wild-type MV strains isolated and passaged in B95a cells induce clinical signs resembling those of human measles in experimentally infected cynomolgus and rhesus monkeys (15, 16) .
A major difference between vaccine and MV wild-type strains in vitro is their cell specificity. Vaccine strains of MV grow efficiently in many human and primate cell lines, whereas wild-type strains of MV grow only in limited lymphoid cell lines. This difference is attributed mainly to the receptor usage of MV strains. The H proteins of wild-type strains recognize the signaling lymphocyte activation molecule (SLAM) (also called CD150), which is expressed in certain immune system cells (36) , and the recently identified nectin-4 (also called PVRL4), which is expressed in ep-ithelial cells in trachea, skin, lung, prostate, and stomach as a cellular receptor (20, 23) . However, the H proteins of MV vaccine strains recognize CD46 (6, 21) in addition to SLAM and nectin-4 as cellular receptors. Since CD46 is expressed in all human and monkey nucleated cells, MV vaccine strains can grow in many human and primate cell lines. Indeed, when the H protein of a wild-type strain of MV was exchanged with that of an MV vaccine strain, the resulting recombinant wild-type MV strain grew in many human and monkey cell lines (12, 28, 35) .
Although the receptor specificity of the H proteins of MV strains has been studied extensively, very little is known about the effect of the H protein on the in vivo tropism and attenuation of MV. Given that the H proteins of MV vaccine strains can use CD46 in addition to SLAM and nectin-4 as cellular receptors, recombinant MV strains bearing the H protein of MV vaccine strains may have an expanded in vivo tropism.
In this study, we generated enhanced green fluorescent protein (EGFP)-expressing recombinant wild-type strains of MV bearing the H protein of the Edmonston MV vaccine strain by using our reverse genetics system (32) and compared the cell specificity in vitro and tropism in vivo with those of EGFP-expressing MV wildtype strains. We found that the H protein of the Edmonston vaccine strain of MV alters the cell specificity of the MV wild-type strain in vitro but does not alter the tropism of the MV wild-type animal experiments were performed in compliance with the guidelines of National Institute of Infectious Disease (Tokyo, Japan).
Macroscopic detection of EGFP fluorescence. EGFP fluorescence in the tissues and organs of cynomolgus monkeys was observed using a VB-G25 fluorescence microscope equipped with a VB-7000/7010 chargecoupled device (CCD) detection system (Keyence, Osaka, Japan). For the respective excitation and the detection of fluorescence, 470/40-nm and 510-nm band-pass filters were used.
Histopathological and immunohistochemical analysis. Animals were anesthetized, and tissues from lung, bronchus, heart, liver, kidney, skin, spleen, mesenteric lymph node (MLN), cervical lymph node, thymus, salivary gland, tonsil, stomach, pancreas, and jejunum were fixed with 10% phosphate-buffered formalin. Fixed tissues were embedded in paraffin, sectioned, and stained with hematoxylin and eosin. Immunohistochemical detection of the N protein of MV was performed on paraffinembedded sections as described previously (34) .
Double immunofluorescence staining. Paraffin-embedded lungs were used for staining the N protein of MV and cytokeratin. The sections were subjected to a double immunofluorescence staining method employing a rabbit antiserum against the N protein and the cytokeratin monoclonal mouse antibody (clone MAB1611; Chemicon, CA). Briefly, after deparaffinization with xylene, the sections were rehydrated in ethanol and immersed in phosphate-buffered saline (PBS). Antigens were retrieved by hydrolytic autoclaving for 15 min at 121°C in the retrieval solution at pH 9.0 (Nichirei, Tokyo, Japan). After cooling, normal goat serum was used to block background staining. The sections were incubated with the anticytokeratin antibody for 30 min at 37°C. After 3 washes in PBS, the sections were incubated with an antiserum against MV N protein for 30 min at 37°C. Antigen-binding sites were detected with goat anti-rabbit Alexa Fluor 488 (Molecular Probes, Eugene, OR) or goat antimouse Alexa Fluor 546 (Molecular Probes) for 30 min at 37°C. The sections were mounted with SlowFade Gold antifade reagent with DAPI (4=,6=-diamidino-2-phenylindole) (Molecular Probes), and the images were captured using a fluorescence microscope (IX71; Olympus, Tokyo, Japan) equipped with a Hamamatsu high-resolution digital B/W CCD camera (ORCA2; Hamamatsu Photonics, Hamamatsu, Japan).
Flow cytometric analysis. PBMCs were stained with the following monoclonal antibodies, which are cross-reactive with macaque cells: CD150-phycoerythrin (PE) clone A12 (BD Pharmingen, San Diego, CA), CD3-allophycocyanin (APC) clone SP34-2 (BD Pharmingen), and CD20-PE/Cy7 clone 2H7 (BioLegend, San Diego, CA). The cells were fixed with 1% paraformaldehyde, and MV-infected cells were detected by the expression of EGFP in the fluorescein isothiocyanate channel. The flow cytometric acquisition of approximately 200,000 to 500,000 events from each sample was performed on a FACSCalibur instrument.
Amplification of MV genomic RNA by real-time reverse transcription-PCR (RT-PCR). Total RNA was isolated from tissues by using the RNAlater and RNeasy kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol, reverse transcribed, and PCR amplified with a Dice TP800 thermal cycler (Takara, Tokyo, Japan) by using Fast-Start SYBR green Master (Roche). For amplification of the MV genome sequence, MV-P1 primer 5=-AGATGCTGACTCTATCATGG-3= (positions 2178 to 2197) was used for RT, and then MV-P1 primer and MV-P2 primer 5=-TCGAGCACATTGGGTTGCAC-3= (positions 2574 to 2555) were used for PCR. For amplification of the 18S RNA segment, the 18S sense primer TCAAGAACGAAAGTCGGAGG and 18S antisense primer GGACATCTAAGGGCATCACA (25) were used. In a separate experiment, we amplified DNA from a known amount of p(ϩ)MV323-EGFP plasmid containing the target region under the same reaction conditions, and the results for the real-time RT-PCR were expressed as genome RNA equivalent to p(ϩ)MV323-EGFP.
Cytokine assay. Cytokine levels in the plasma were measured with a Luminex 200 instrument (Luminex, Austin, TX) by using a Milliplex nonhuman primate cytokine/chemokine kit (Millipore, Billerica, MA) according to the manufacturer's instructions. The assay sensitivities were as follows; interleukin-12/23 (IL-12/23) (p40), 1.11 pg/ml; gamma interferon (IFN-␥), 0.30 pg/ml; IL-2, 0.73 pg/ml; IL-4, 1.25 pg/ml; IL-5, 0.26 pg/ml; IL-17, 0.13 pg/ml; IL-6, 0.40 pg/ml; tumor necrosis factor alpha (TNF-␣), 0.86 pg/ml; IL-1␤, 0.16 pg/ml; and monocyte chemoattractant protein 1 (MCP-1), 0.91 pg/ml.
RESULTS

Generation of recombinant MV strains expressing EGFP.
To compare the cell specificities in vitro of wild-type MV and wildtype MV bearing the H protein of the Edmonston vaccine strain, we generated EdH-EGFP from wild-type IC323-EGFP (12). IC323-EGFP and EdH-EGFP ( Fig. 1A) have the EGFP gene preceding the N gene and induce a strong EGFP fluorescence in infected monolayer cells. For in vivo infection, we generated IC323-EGFP 2 and EdH-EGFP 2 (Fig. 1A) , having the EGFP gene between the F and H genes, because a previous report using canine distemper virus (CDV) indicated that a CDV strain having the EGFP gene preceding the N gene had reduced overall CDV gene expression and was less virulent (38) . IC323-EGFP 2 and EdH-EGFP 2 induced very weak EGFP fluorescence in infected monolayer cells (data not shown) because of the polar effect of paramyxovirus transcription (17) .
Infection of primary cell culture with recombinant MV strains. We first examined the cell specificities of IC323-EGFP and EdH-EGFP in vitro. In B95a cells, both IC323-EGFP and EdH-EGFP induced large syncytia and strong EGFP expression, whereas in Vero cells, only EdH-EGFP induced syncytia and strong EGFP expression ( Fig. 1B) , consistent with our previous observation (35) . Notably, EdH-EGFP induced large syncytia and strong EGFP expression in primary kidney and primary astroglial cells derived from cynomolgus monkey tissues ( Fig. 1B) . Thus, the H protein of the Edmonston vaccine strain of MV can expand the in vitro cell specificity of the wild-type MV strain in established cell lines as well as in primary cell cultures of cynomolgus monkey tissues.
Preliminary infection of cynomolgus monkeys with recombinant MV strains. We next examined the in vivo tropism and growth of IC323-EGFP 2 and EdH-EGFP 2 by using 3 cynomolgus Schematic diagram of the genomic organizations of IC323-EGFP, EdH-EGFP, IC323-EGFP 2 , and EdH-EGFP 2 . (B) B95a, Vero, primary cynomolgus monkey kidney, and primary cynomolgus monkey astroglial, cells were infected with IC323-EGFP or EdH-EGFP. The MV-infected cells were visualized with EGFP autofluorescence at day 2 (B95a), day 3 (Vero), day 4 (primary kidney), or day 3 (primary astroglia). (C) Replication kinetics of IC323-EGFP 2 and EdH-EGFP 2 . B95a cells and Vero cells were infected with IC323-EGFP 2 (circles) or EdH-EGFP 2 (triangles) at a multiplicity of infection (MOI) of 0.01 tissue culture infective dose (TCID 50 )/cell. Cells and media were harvested at days 0, 1, 2, 3, and 4, and infectivity titers were assessed as TCID 50 using B95a cells.
monkeys. Prior to the infection of monkeys with IC323-EGFP 2 and EdH-EGFP 2 , we examined the in vitro cell specificities of the two strains by using B95a and Vero cells and confirmed that EdH-EGFP 2 had the wider in vitro cell specificity (Fig. 1C ). Then, one monkey (no. 4850) was inoculated with IC323-EGFP 2 , and two monkeys (no. 4848 and 4849) were inoculated with EdH-EGFP 2 .
At day 7, viremia was observed in all 3 monkeys ( Fig. 2A) . Upon necropsy at day 7, nearly the same numbers of MV-infected cells were isolated from the cervical lymph nodes of the 3 monkeys ( Fig.  2A) . EGFP fluorescence was observed in many lymphoid tissues, including the cervical lymph nodes, tongue, tonsils, stomach, and gut-associated lymph nodes, in the 3 monkeys ( Fig. 2B) . No sig- nificant difference in the distributions and intensities of EGFP fluorescence in the internal organs and tissues was observed among the 3 monkeys, indicating that the tropism of EdH-EGFP 2 was not expanded in vivo.
Growth of recombinant MV strains in cynomolgus monkeys. To assess whether these results could be confirmed, 6 monkeys were infected with IC323-EGFP 2 or EdH-EGFP 2 . Three monkeys (no. 5058, 5062, and 5069) were inoculated with IC323-EGFP 2 , and 3 monkeys (no. 5056, 5057, and 5068) were inoculated with EdH-EGFP 2 . At day 7, viremia was detected in all 6 monkeys, and the number of infected cells was increased at day 10 in most monkeys (Fig. 3A, left) . Upon necropsy at day 10, MV-infected cells were isolated from the cervical lymph nodes and spleens of the 6 monkeys ( Fig. 3A, right) . In monkeys infected with IC323-EGFP 2 a large number of the lymphocytes (up to 49%) of cervical lymph nodes were infected, whereas in monkeys infected with EdH-EGFP 2 , a smaller number (0.040 to 0.77%) of the lymphocytes of cervical lymph nodes were infected (Fig. 3A, right) . Similarly, in monkeys infected with IC323-EGFP 2 , a large number of the lymphocytes (up to 8.2%) in the spleen were infected, whereas in monkeys infected with EdH-EGFP 2 , a smaller number (0.032 to 1.5%) of the lymphocytes in cervical lymph nodes were infected (Fig. 3A, right) . In all 6 monkeys infected with either IC323-EGFP 2 or EdH-EGFP 2 , substantial amounts of MV genome RNA were detected in the tonsils, cervical lymph nodes, thymus, spleen, mesenteric lymph nodes, inguinal lymph nodes, bone marrow, and lungs (Fig. 3B ). We note that the amount of MV genome RNA in EdH-EGFP 2 -infected monkeys was significantly lower than that in IC323-EGFP 2 -infected monkeys, especially in lungs.
Macroscopic detection of EGFP fluorescence in organs and tissues. In all 6 monkeys infected by IC323-EGFP 2 or EdH-EGFP 2 , EGFP fluorescence was macroscopically detected in many lymphoid organs and tissues, including the tongue and tonsils, thymus, trachea and lungs, stomach, and gut-associated lymph nodes, upon necropsy at day 10 ( Fig. 4) . No difference in the distribution of EGFP fluorescence in the internal organs and tis-sues was observed between monkeys infected with IC323-EGFP 2 or EdH-EGFP 2 , confirming that tropism of EdH-EGFP 2 is not expanded in macaques. However, the intensity of EGFP fluorescence in the internal organs and tissues of EdH-EGFP 2 -infected monkeys was significantly weaker than that in IC323-EGFP 2infected monkeys.
Histopathological and immunohistochemical analyses. To further examine the tissue and organ tropism of IC323-EGFP 2 and EdH-EGFP 2 , we performed histopathological and immunohistochemical analyses of fixed specimens. In bronchioles, we histo- pathologically observed bronchiolitis and giant cells with eosinophilic inclusion bodies in monkeys infected with both IC323-EGFP 2 and EdH-EGFP 2 , and MV N antigen was detected in both sections (Fig. 5A) . Tissue sections obtained from the bronchiole area were double stained with anti-MV N and anticytokeratin antibodies, which clearly showed infection of EdH-EGFP 2 in the epithelial cells (Fig. 5B) as reported for wild-type MV (3, 20) , possibly through a nectin-4-mediated pathway (18, 20, 23, 31) . Interestingly, the N protein was accumulated under the apical plasma membrane of the infected cells ( Fig. 5B ), suggesting an intracellular mechanism of transport of the N protein to the apical plasma membrane. The MV N antigen was detected in the lymphocytes of the spleen, mesenteric and cervical lymph nodes, thymus, salivary gland, tonsils, stomach, and jejunum (Table 1) , as well as in epithelia of the lungs, bronchi, tonsils, and stomach, but not in the muscles of the heart and in the epithelia of the liver, kidney, skin, tonsils, and stomach of most monkeys. These data again indicated that tropism of EdH-EGFP 2 was not expanded in macaques.
Flow cytometric analysis. To examine the cell tropism of IC323-EGFP 2 and EdH-EGFP 2 in lymphocytes, EGFP expression in lymphocytes isolated from PBMCs and mesenteric lymph nodes was analyzed by flow cytometry. A total of 0.90% and 8.59% of B lymphocytes in PBMCs and MLNs, respectively, and 0.90% and 3.90% of T lymphocytes in PBMCs and MLNs, respectively, were infected with IC323-EGFP 2 (Fig. 6 ). Lymphocytes expressing SLAM were infected with IC323-EGFP 2 , as previously reported (3) . Similarly, 0.44 to 0.53% and 1.06 to 2.23% of B lymphocytes in PBMCs and MLNs, respectively, and 0.42 to 0.68% and 0.70 to 1.44% of T lymphocytes in PBMCs and MLNs, respectively, were infected with EdH-EGFP 2 (Fig. 6 ). Lymphocytes expressing SLAM were also infected with EdH-EGFP 2 . These results indicated that tropism of EdH-EGFP 2 was not expanded in lymphocytes of macaques. Interestingly, the number and intensity of EGFP-expressing cells in lymphocytes of EdH-EGFP 2 -infected monkeys were significantly lower than those in of IC323-EGFP 2infected monkeys.
Cytokine production by infected monkeys. To investigate whether the differences in growth of IC323-EGFP 2 and EdH-EGFP 2 in monkeys were associated with altered host responses to infection, we measured cytokine and chemokine levels in plasma samples from infected monkeys. The cytokines selected for analysis were IL-12, IFN-␥, IL-2, IL-4, IL-5, and IL-17 (Th1/Th2 balance) and the IL-6, TNF-␣, IL-1␤, and MCP-1 (inflammatory response).
With Th1-type cytokines, we found that plasma levels of IL-12 were high for 3 (no. 5056, 5057, and 5062) out of 6 monkeys at day 0, were slightly elevated at day 3, and then declined by day 7 (Fig.  7) . The plasma levels of IL-12 for the 3 other monkeys (no. 5058, 5068, and 5069) were low throughout the experiment. Irrespective of the plasma levels of IL-12, the plasma levels of IFN-␥ were elevated in all 6 monkeys. The increase in plasma levels of IL-2 was marginal by day 10 for 5 monkeys. For inflammatory cytokines, the plasma level of MCP-1 was markedly elevated for all monkeys. IL-4, IL-17, and IL-1␤ were not detected throughout the experi-ment. Other cytokines (IL-5, IL-6, and TNF-␣) were not consistently detected (data not shown).
Taking the results together, there were no significant differences in the cytokine production profiles of the monkeys infected with IC323-EGFP 2 or EdH-EGFP 2 , and similar Th1-type and inflammatory responses against acute MV infection occurred in monkeys infected with IC323-EGFP 2 or EdH-EGFP 2 .
DISCUSSION
In this study, we compared the cell specificities and tropisms of the wild-type strains of MV bearing the H protein of the Edmonston vaccine strain with those of the wild-type MV strains. Although EdH-EGFP showed wider cell specificity in cell lines and primary cell cultures (Fig. 1B) , the tissue and organ tropism of EdH-EGFP 2 was not altered in all 5 infected macaques ( Fig. 2 and 4 and Table  1 ). Since CD46 is ubiquitously expressed in human and monkey cells, EdH-EGFP 2 could infect all cells in macaques. However, widespread infection of EdH-EGFP 2 in tissues and organs was not observed. This result is not surprising because it was reported that only the lymph nodes and spleen of monkeys were infected with MV vaccine strains (39) . Furthermore, it was recently reported that CD11c-positive myeloid cells, such as alveolar macrophages and dendritic cells in lungs of monkeys, were infected with an EGFP-expressing recombinant Edmonston strain of MV via an aerosol route (5) . This result is consistent with our findings in that the CD46-using Edmonston vaccine strain does not cause widespread infection in the lungs of monkeys, although there is a possibility that the infection by the Edmonston strain in lungs may be restricted due to mutations in the N and P/C/V genes, which are most important in combating the innate immune system.
One possible explanation for the limited infection of EdH-EGFP 2 in macaques is the expression level of CD46. Anderson et al. reported that at low CD46 density, infection with the MV vac- interferon-inducing activity and permit poliovirus replication when the cells are cultured in vitro (40) . MV replication in monkey tissues may be inhibited by interferon, whereas MV replication in primary cell cultures can occur due to the lack of interferoninducing activity. Flow cytometric analysis showed that lymphocytes expressing SLAM were infected with both IC323-EGFP 2 and EdH-EGFP 2 (Fig. 6 ). It is known that stimulated lymphocytes can be efficiently infected with MV and that SLAM is highly expressed in stimulated lymphocytes (11) . Thus, the activation status of lymphocytes may be important for infection with MV, and infection of unstimulated lymphocytes with EdH-EGFP 2 by the CD46-mediated pathway would not result in efficient MV replication. As a result, lymphocytes expressing SLAM may appear to be equally infected with both strains. Recently, two groups revealed that both SLAM and CD46 are required for stable transduction of resting human lymphocytes with lentiviral vectors pseudotyped with the vaccine MV F and H proteins (8, 42) . Thus, another possibility is that SLAM binding in addition to CD46 binding may be required for efficient infection of lymphocytes with EdH-EGFP 2 . SLAM binding and subsequent signaling (8, 42 ) may be important for efficient MV infection.
A previous study in which monkeys were infected with pathogenic and Edmonston vaccine strains via an aerosol route showed that only the pathogenic strain caused massive infection in lymphoid tissues (5) . We also infected monkeys with IC323-EGFP 2 and EdH-EGFP 2 via the aerosol route, and we found that both strains caused massive infection in lymphoid tissues (Fig. 3 ). This result indicated that the Edmonston H protein does not influence the extent of infection in lymphoid tissues. Proteins other than the H protein, possibly viral polymerase proteins (30) , may regulate MV replication in lymphoid tissues.
Suppression of the production of IL-12 during measles was proposed (10) . We found that the initial level of IL-12 was high for 3 monkeys (no. 5056, 5057, and 5062) but low for 3 other monkeys (no. 5058, 5068, and 5069) ( Fig. 7) . We do not have an explanation for this difference. However, our results indicated that the IL-12 levels were not significantly induced at early time points during MV infection. This result may be consistent with a previous observation of suppressed serum levels of IL-12 during MV infection in rhesus macaques (13, 26) . Interestingly, Th1-type cytokines (IFN-␥ and IL-2) were induced in all monkeys irrespective of the IL-12 level. The induction of IFN-␥ in plasma at early time points is consistent with that in previous studies of human measles (10, 19, 24, 41) . A previous study showed no significant induction of IL-2, IL-12, and IFN-␥ in monkeys infected with wild-type MV (4) . However, in that experiment the induction of IL-2, IL-12, and IFN-␥ was measured by quantitating their mRNAs by real-time RT-PCR using RNA extracted from PBMCs. Real-time RT-PCR data may not coincide with the actual amounts of cytokines in plasma.
In summary, the current study showed that the H protein of the Edmonston vaccine strain alters the cell specificity of wild-type MV in vitro but not the tropism in macaques. SLAM ϩ cells were main target for both IC323-EGFP 2 and EdH-EGFP 2 in macaques. In addition, it is suggested that the Edmonston vaccine H protein attenuates MV growth in vivo, especially at a later stage. It has long been proposed that the vaccine H protein attenuates the virus growth in vivo by several mechanisms (e.g., CD46-mediated signaling in infected cells or downregulation of CD46 in infected cells and subsequent complement-mediated cell lysis) (14) . It will be interesting to examine the type I interferon production and the downregulation of CD46 in MV-infected cells in monkeys infected with EdH-EGFP 2 or MV vaccine strains.
